Cocoa beans were known to be the valuable cash crops of Southern America. It had an important role in many ancient South American cultures. The Mayans in the early days used cocoa to make a ritual beverage that was shared among the people during marriage ceremonies and betrothal. Cocoa beans have been used since centuries and have gained high demand in the market today.
Growth in healthcare investments, prevalence of angioedema and growing high-risk geriatric population are the major factors driving the global market growth for angioedema treatment. In the next few years the demand for angioedema treatment is expected to increase significantly in the economies such as China and Japan. Rising incidence of hereditary angioedema and high awareness about treatment and the management of angioedema together drive the global hereditary angioedema market.
The actinic keratosis (AK) treatment market is anticipated to grow at a CAGR of about 4.5% during the forecast period 2025-2033. In skin care, occurrence of rough, scaly, crusty, thick patches on the skin surface showing premalignant condition is referred as actinic keratosis.
Essential oils have its existence around the globe for centuries as a healing agent and for various application due to its aroma and flavor properties. The use of essential oil dated since 4500 B.C.E., by the Egyptians for medicinal uses and beauty products. Since then the essentials oils have been known to mankind as a healing agent and as a beauty product due to its aroma. Wide range of essential oils are present in the market which are used in various end-user industries including food, cosmetic and personal care products, pharmaceutical and household cleaning products among others.
Air quality monitoring equipment enables continuous and on-demand assessment of both indoor and outdoor air quality. Air quality monitoring equipment makes use of various sensors which detect the presence of various pollutant particles either chemical, physical or biological. The combination of a number of sensors enables the equipment to provide with a comprehensive report on the air quality within and around any facility.
The global wound care market involves various products that help in healing and preventing infection. Wound care & closure and advanced wound care & closure products are used to treat acute and chronic wounds. Chronic wounds are hard to heal and take substantial time to heal. In the next few years the demand for wound care products room is expected to increase significantly in the emerging economies such as China and India.
Malic acid, it is adicarboxylic acid which is used an active ingredient in many food products. Malic acid exhibits the properties such as controlling the microorganisms’ growth, adjusting pH, and also flavour enhancement which makes it highly preferable for usage in the food and beverage industry. It also imparts a very pleasant flavor when added in food and beverages. Therefore, it is significantly used in the food and beverage industry where it is used in various products such as bakery products, fruit juices, sports drinks, carbonated beverages, desserts and frozen specialities.
Global Human Chorionic Gonadotropin Market is having an exponential growth rate of 7.5% from 2025 to 2033. Fertility patterns worldwide have changed dramatically and a rise in the infertility rates have been observed since the last two decades. Even though newer assisted techniques such as in-vitro fertilization have been well developed, still fertility drugs are the first choice for treatment of infertility issues. Even in the fertility drugs category, hormonal products are preferred the most. Since the human body is governed by hormones, infertility is considered to be caused due to the abnormal play of the hormones.
The medical gases industry is currently undergoing shift in standards and delivery due to modernization of institutional healthcare and home healthcare market and the means of supply to these areas. The medical gas sector is anticipated to undergo certain revisions in testing and supply requirements from the developed markets.
The global market for plant stem cells is expected to grow at a CAGR of 8.5% during the forecast period of 2025 to 2033. Plant stem cells are cells that have not yet undergone any sort of differentiation and can be found in the meristems of plants. Gemmotherapy is another name for the treatment of diseases using plant stem cells. These stem cells find usage in a wide variety of applications, including those dealing with protein therapy, health care, and skincare.
The drugs by therapeutic area market covers pharmaceutical products classified according to the diseases and medical conditions they are designed to treat. Major therapeutic areas include oncology, cardiovascular diseases, diabetes and other metabolic disorders, neurological conditions, infectious diseases, respiratory disorders, immunology, gastrointestinal diseases, dermatology, ophthalmology, women’s health and rare diseases. The category includes prescription drugs, generic medicines, biologics, biosimilars, vaccines and advanced therapies.
The wider global pharmaceutical market provides an appropriate benchmark for evaluating growth across therapeutic drug categories. One current industry estimate projects the pharmaceutical market to increase from approximately USD 1.88 trillion in 2026 to USD 3.22 trillion by 2035, representing a compound annual growth rate of 6.15%. North America held the largest regional share in 2025, while Asia-Pacific is expected to demonstrate notable growth through 2035.
Market growth is being supported by the increasing prevalence of chronic and age-related diseases. Rising cases of cancer, diabetes, cardiovascular disorders, arthritis, respiratory diseases and neurological conditions are creating sustained demand for effective treatments. Population ageing, lifestyle changes, urbanization and improved access to diagnosis are further expanding the number of patients receiving long-term therapy.
Oncology remains an important area for pharmaceutical research and commercial investment. Development activity includes targeted therapies, immune checkpoint inhibitors, antibody-drug conjugates, cell therapies and personalized cancer treatments. Diabetes and obesity drugs are also recording strong demand, supported by the wider use of GLP-1 and other metabolic treatments. Neurology research is expanding across Alzheimer’s disease, Parkinson’s disease, epilepsy and mental health conditions.
Biologic drugs and biosimilars represent major market trends. Biologics are increasingly used to treat cancer, autoimmune diseases and rare disorders, while biosimilars can improve access after reference-product patent expiry. Pharmaceutical companies are also developing gene therapies, RNA-based medicines and other advanced treatments for conditions with limited existing options.
Precision medicine is influencing drug development across multiple therapeutic areas. Biomarkers, genomic testing and companion diagnostics help identify patients who are more likely to respond to specific medicines. Artificial intelligence is also being used for target identification, clinical-trial planning and analysis of real-world treatment data.
Market expansion may be restrained by high research costs, lengthy clinical development, regulatory uncertainty and drug-pricing pressure. Patent expirations can reduce revenue for branded products, while safety concerns or unsuccessful clinical trials may delay commercial launches. Access and reimbursement remain major challenges for expensive biologics and advanced therapies.
Acute Market Reports provides therapeutic-area drug research covering product classes, disease indications, routes of administration, distribution channels, company pipelines, competitive conditions and regional opportunities. These reports help pharmaceutical companies, investors, healthcare providers and distributors evaluate treatment demand and growth prospects through 2035.